BSX News and Press, Boston Scientific Corporation

2024-07-16 13:01:00 ET Short percentage in S&P 500’s healthcare companies rose slightly at the end of June from May as biotechnology industry continued to emerge as the most shorted sector, while most other sectors saw meager change in interest from last month.... Read the ...

Shares of Boston Scientific Corporation (NYSE: BSX) traded at a new 52-week high today and are currently trading at $78.31. So far today, approximately 1.5M shares have been exchanged, as compared to an average 30-day volume of 5.37M shares. Boston Scientific Corporation develops, manufacture...

2024-07-10 12:52:04 ET More on Glaukos, Intuitive Surgical, etc. Glaukos Stock: Still Unproven Whether A New Bull Market Has Begun Tandem Diabetes Care: Recent Rally Fully Deserved, Likely More Upside Here Intuitive Surgical: Hope For A Resurgence In Operational Leve...

2024-07-08 14:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-07-08 10:41:56 ET More on Pulse Biosciences Pulse Biosciences Stock: Signs Of Life Following Q1 Update Pulse Biosciences Inc (PLSE) Q1 2024 Earnings Call Transcript Pulse Biosciences announces updated timing of rights offering for up to $60M Pulse Biosci...

2024-07-07 09:00:00 ET Summary BlackRock Health Sciences Trust is a healthcare sector-specific closed-end fund that invests in a fairly diversified portfolio of common stocks in the healthcare sector. It currently provides a reasonable yield of 6.3% plus an attractive discount of ...

2024-07-03 09:58:47 ET Summary JNJ shares have underperformed for years, with multiple contributing causes including upcoming generic competition for Stelara, uncertainty around talc litigation, and questions about internal growth capabilities. The pharmaceutical pipeline shows pr...

2024-07-02 09:15:03 ET Evercore ISI analyst issues OUTPERFORM recommendation for BSX on July 2, 2024 08:01AM ET. The previous analyst recommendation was Outperform. BSX was trading at $76.41 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-07-01 12:35:40 ET More on Zimmer Biomet Zimmer Biomet Holdings: Moving Along Zimmer Biomet Holdings, Inc. (ZBH) Q1 2024 Earnings Call Transcript Zimmer Biomet down for third session in a row despite THINK Surgical agreement Argus upgrades Zimmer to buy, ...

Boston Scientific Announces Conference Call Discussing Second Quarter 2024 Results PR Newswire MARLBOROUGH, Mass. , July 1, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business h...